Lv21
158 积分 2025-07-27 加入
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera®) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial
9天前
已完结
Cell-of-Origin Subtypes and Therapeutic Benefit from Polatuzumab Vedotin
10天前
已完结
Unmet needs in the first-line treatment of diffuse large B-cell lymphoma: Expert recommendations from the Asia-Pacific region with a focus on the challenging subtypes
10天前
已完结
Contemporary management of diffuse large B-cell lymphoma in Japan
10天前
已完结
Targeting epigenetic reprogramming in DLBCL and its interaction with the tumor microenvironment for novel therapeutic approaches
10天前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
10天前
已完结
A preliminary study on establishment of AI-assisted remote imaging diagnosis system for major infectious diseases
13天前
已完结
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update
14天前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
22天前
已完结
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
23天前
已完结
皖公网安备34019202002308
